Giesecke, J.; Oskarsson, A.; Petersson, M.; Nordenvall, A.S.; Tettamanti, G.; Nordgren, A.; Höybye, C.
Comorbidities, Endocrine Medications, and Mortality in Prader–Willi Syndrome—A Swedish Register Study. J. Clin. Med. 2025, 14, 1307.
https://doi.org/10.3390/jcm14041307
AMA Style
Giesecke J, Oskarsson A, Petersson M, Nordenvall AS, Tettamanti G, Nordgren A, Höybye C.
Comorbidities, Endocrine Medications, and Mortality in Prader–Willi Syndrome—A Swedish Register Study. Journal of Clinical Medicine. 2025; 14(4):1307.
https://doi.org/10.3390/jcm14041307
Chicago/Turabian Style
Giesecke, Julia, Anna Oskarsson, Maria Petersson, Anna Skarin Nordenvall, Giorgio Tettamanti, Ann Nordgren, and Charlotte Höybye.
2025. "Comorbidities, Endocrine Medications, and Mortality in Prader–Willi Syndrome—A Swedish Register Study" Journal of Clinical Medicine 14, no. 4: 1307.
https://doi.org/10.3390/jcm14041307
APA Style
Giesecke, J., Oskarsson, A., Petersson, M., Nordenvall, A. S., Tettamanti, G., Nordgren, A., & Höybye, C.
(2025). Comorbidities, Endocrine Medications, and Mortality in Prader–Willi Syndrome—A Swedish Register Study. Journal of Clinical Medicine, 14(4), 1307.
https://doi.org/10.3390/jcm14041307